Orion Corporation, founded in 1917 and headquartered in Espoo, Finland, operates in the global pharmaceutical industry. As a developer, manufacturer, and marketer of human and veterinary pharmaceuticals, the company specializes in central nervous system disorders, oncology, and respiratory diseases, offering products like the Easyhaler® pulmonary drugs. Celebrating its centennial in 2017, Orion reported net sales of EUR 1,074 million and employed approximately 3,500 people, with its shares traded on Nasdaq Helsinki.